Acrotech Biopharma
NJ - East WindsorPharmaceutical
Focus: Acrotech Biopharma is a publicly traded specialty pharmaceutical company headquartered in New Jersey, focused on oncology and specialty therapeutics with a portfolio of marketed drugs in peak and approaching loss-of-exclusivity phases.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Acrotech Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow Acrotech Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Acrotech Biopharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
1 imminent
BELEODAQ
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Stable
Peak
Established oncology asset in peak commercial phase; liposomal formulation in Phase 1/2 trials for acute lymphoblastic leukemia expansion.
Help build intelligence for Acrotech Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.